Vaccine increases disease-free survival for follicular lymphoma patients: Study on personalized therapy may lead to a 'flood of new agents'
Tuesday, May 31, 2011 - 18:30
in Health & Medicine
A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, scientists have reported.